检索历史 清除

通过专家投票方式遴选出了能够代表近5年我国眼底病临床与基础研究最突出的10项研究进展.这些研究既涵盖了脉络膜新生血管性疾病、小儿视网膜疾病、息肉状脉络膜血管病变、眼内恶性肿瘤、特殊病原体眼内感染等疾病,又包括抗VEGF药物、光动力疗法、微创玻璃体切除手术、眼内注射等治疗手段以及眼底病新药临床评价研究中心和眼底病流行病学研究等领域.这些研究进展在很大程度上能够代表目前我国眼底病学者在国际眼底病学界的水平和影响力,甚至成为我国眼底病学者标志性的研究成果.

Ten research items in the past five years representing the progression of clinical research in fundus diseases in China were voted by specialists from the Ocular Fundus Disease Group of Ophthalmology Society of Chinese Medical Association.Choroidal neovascular disease,pediatric retinal disease,polypoidal choroidal vasculopathy,intraocular malignant tumor,and intraocular infection caused by specific pathogens are covered.Novel treatment,like anti-VEGF medication,PDT,minimally invasive vitrectomy,and intraocular injection,establishment of the Clinical Research Center of New Drug Development,and the epidemiologic study of fundus diseases are also included.These landmark research progressions represent the power and influence of Chinese fundus disease scholars in the world.